innoVitro

As a CRO, innoVitro specializes in human-cell analytics for drug safety, toxicity, and efficacy in preclinical cardiac risk assessment.

Anivance AI Corporation

Anivance AI combines organ chips with Multi-Agent AI. With 35 patents and global collaborations, we deliver plug-and-play platforms and LaaS services, supporting rare disease and inhalation models, diverse preclinical studies, and predictive, clinically-relevant data for accelerated drug discovery.

Nagi Bioscience

We are a Swiss high-tech company developing and offering cutting-edge biological testing solutions that enable scientists to generate insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our technologies are designed to integrate seamlessly into existing lab environments, enhancing efficiency, accuracy, and reproducibility.